Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04969887
Title Combination Immunotherapy in Rare Cancers Under InvesTigation (MOST-CIRCUIT)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Olivia Newton-John Cancer Research Institute
Indications

biliary tract cancer

intrahepatic cholangiocarcinoma

uterus leiomyosarcoma

vaginal squamous tumor

ovarian carcinosarcoma

uterine carcinosarcoma

Advanced Solid Tumor

vulva squamous cell carcinoma

ovarian clear cell carcinoma

neuroendocrine carcinoma

endometrial clear cell adenocarcinoma

gallbladder carcinoma

Therapies

Ipilimumab + Nivolumab

Age Groups: senior | adult
Covered Countries


No variant requirements are available.